Literature DB >> 8383245

A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor.

W S Blair1, X Li, B L Semler.   

Abstract

The production of poliovirus capsid proteins from a capsid protein precursor (P1) is mediated by virus-encoded proteinase 3CD and involves a complicated set of proteinase-substrate interactions. In addition to substrate and enzymatic determinants required for this interaction, we describe a cellular cofactor, which facilitates 3CD recognition of the P1 precursor. Cellular cofactor activity is 3CD dependent and salt dependent. Our analysis shows that proteolytic cleavage of the P1 precursor at the VP0/VP3 cleavage site exhibits a greater dependency on the cellular cofactor than cleavage at the VP3/VP1 site. Such a greater dependency on cellular cofactor activity can be relieved (in part) by the substitution of an Ala residue for the Pro residue at the -4 position of the VP0/VP3 cleavage site. However, mutant viruses containing Pro-to-Ala substitutions at the -4 position of the VP0/VP3 site exhibit defects in viral growth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383245      PMCID: PMC240391     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash.

Authors:  B A Brown; E Ehrenfeld
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

2.  Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.

Authors:  M F Ypma-Wong; B L Semler
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Infectious poliovirus RNA: a sensitive method of assay.

Authors:  A Vaheri; J S Pagano
Journal:  Virology       Date:  1965-11       Impact factor: 3.616

4.  Cleavage sites within the poliovirus capsid protein precursors.

Authors:  G R Larsen; C W Anderson; A J Dorner; B L Semler; E Wimmer
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

5.  Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites.

Authors:  E A Emini; M Elzinga; E Wimmer
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

6.  An SV40 deletion mutant accumulates late transcripts in a paranuclear extract.

Authors:  R Campos; L P Villarreal
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

7.  In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate.

Authors:  A J Dorner; B L Semler; R J Jackson; R Hanecak; E Duprey; E Wimmer
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.

Authors:  H Toyoda; M J Nicklin; M G Murray; C W Anderson; J J Dunn; F W Studier; E Wimmer
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

9.  Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs.

Authors:  R Hanecak; B L Semler; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

10.  Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing.

Authors:  B L Semler; C W Anderson; N Kitamura; P G Rothberg; W L Wishart; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  11 in total

1.  Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC.

Authors:  Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 2.  Transgenic cell lines for detection of animal viruses.

Authors:  P D Olivo
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 3.  Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions.

Authors:  A G Porter
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis.

Authors:  G van Marle; L C van Dinten; W J Spaan; W Luytjes; E J Snijder
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Processing of a cellular polypeptide by 3CD proteinase is required for poliovirus ribonucleoprotein complex formation.

Authors:  H H Roehl; T B Parsley; T V Ho; B L Semler
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells.

Authors:  Gaël Belliot; Stanislav V Sosnovtsev; Tanaji Mitra; Carl Hammer; Mark Garfield; Kim Y Green
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Proteolytic processing of the open reading frame 1b-encoded part of arterivirus replicase is mediated by nsp4 serine protease and Is essential for virus replication.

Authors:  L C van Dinten; S Rensen; A E Gorbalenya; E J Snijder
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates.

Authors:  T Schultheiss; W Sommergruber; Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants.

Authors:  Hyung Suk Oh; Harsh B Pathak; Ian G Goodfellow; Jamie J Arnold; Craig E Cameron
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers.

Authors:  Joseph Newman; Amin S Asfor; Stephen Berryman; Terry Jackson; Stephen Curry; Tobias J Tuthill
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.